Anebulo Pharmaceuticals, Inc.
(NASDAQ : ANEB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.36%168.170.7%$1128.57m
PFEPfizer Inc. -0.66%49.530.9%$922.14m
ABBVAbbVie, Inc. -0.46%141.891.9%$815.95m
LLYEli Lilly & Co. 2.67%318.591.1%$806.09m
MRKMerck & Co., Inc. 0.83%91.350.7%$799.56m
BMYBristol-Myers Squibb Co. 0.96%74.841.0%$652.13m
SIGASIGA Technologies, Inc. 1.85%24.770.0%$472.84m
AZNAstraZeneca Plc -0.05%66.711.0%$369.50m
GBTGlobal Blood Therapeutics, Inc. 0.06%67.045.6%$332.93m
GSKGSK Plc -1.42%34.760.3%$280.21m
ALNYAlnylam Pharmaceuticals, Inc. -1.19%225.448.2%$273.24m
VERUVeru, Inc. 8.40%24.120.0%$243.04m
HZNPHorizon Therapeutics Plc -2.54%62.455.4%$214.94m
KRTXKaruna Therapeutics, Inc. 0.52%265.060.0%$206.09m
CCXIChemoCentryx, Inc. 0.10%50.912.9%$202.52m

Company Profile

Anebulo Pharmaceuticals, Inc. engages in the provision of pharmaceutical services. The firm product candidate is ANEB-001, a potent, small molecule cannabinoid receptor antagonist, designed to address the unmet medical need for a specific antidote for cannabinoid overdose. The company was founded by Lawyer Joseph F on April 23, 2020 and is headquartered in Lakeway, TX.